ARTICLES LIST

 

Total Results: 16203

Media ID Source Name Media Type Language Media Name Media Description Keywords Keywords Link to Article
1462 National Cancer Institute Html en Gastrointestinal Carcinoid Tumors Treatment (PDQ®)–Health Professional Version Expert-reviewed information summary about the treatment of gastrointestinal carcinoid tumors.
low-grade neuroendocrine tumors0.396019
duodenal carcinoid tumor0.397268
multifocal neuroendocrine tumors0.421413
carcinoid patients0.422833
relatively common carcinoids0.388053
midgut neuroendocrine tumors0.400819
midgut carcinoids0.398106
carcinoid neuroendocrine tumors0.530837
carcinoid heart failure.0.412799
midgut carcinoid syndrome0.494495
tract carcinoid tumors0.466207
sporadic neuroendocrine tumors0.41799
carcinoid heart disease0.604399
multiple carcinoid tumors0.498345
patients0.441078
Pract Res Clin0.384377
gastric carcinoids0.406312
carcinoid symptoms0.386144
Malignant carcinoid tumors0.458841
ileal carcinoids0.443228
carcinoid tumors0.921678
Carcinoid Tumors section0.552577
Gastrointestinal carcinoids0.396139
term carcinoid0.38666
gut neuroendocrine tumors0.405828
gastric argyrophil carcinoid0.39372
neuroendocrine tumors0.772231
et al.0.477186
carcinoid syndrome.0.396106
renal carcinoid tumor0.400621
rectal carcinoids0.465534
Gastrointestinal Carcinoid Tumors0.556816
rectal carcinoid patients0.421651
carcinoids0.607075
PUBMED Abstract0.470567
multiple endocrine neoplasia0.391617
frequent carcinoid tumor0.405695
5-year survival0.39049
neuroendocrine tumours0.472335
neuroendocrine gastrointestinal tumors0.422781
Pancreatic Neuroendocrine Tumors0.446589
well-differentiated neuroendocrine tumors0.443559
Abstract0.585558
gastrointestinal carcinoid tumor0.427766
carcinoid syndrome0.595242
severe carcinoid heart0.411522
gastroenteropancreatic neuroendocrine tumors0.419971
metastatic carcinoid tumors0.588139
duodenal carcinoids0.494906
CLICK HERE
1646 National Cancer Institute Html en Cancer Screening Overview (PDQ®)–Patient Version Information about measuring the effectiveness of cancer screening tests and about weighing the strength of the evidence obtained from cancer screening research studies.
new screening test0.617185
health care provider0.670679
odds ratio0.601994
PDQ cancer information0.657991
clinical trials0.728892
cervical cancer rates0.56941
test result0.575182
cancer information summary0.627344
group0.594884
clinical trial0.572791
test results0.625142
breast cancer prevention0.567805
cancer patients0.585953
PDQ® Screening0.567153
cancer risk factor0.586088
cervical cancer0.569926
relative risk0.572167
symptoms0.56993
cancer symptoms0.5675
NCI PDQ cancer0.589008
accurate cancer screening0.616077
useful cancer screening0.649307
PDQ Screening0.5802
Cancer Information Service0.580898
useful screening test0.597804
Prevention Editorial Board0.577411
certain disease0.568589
National Cancer Institute0.720252
studies0.621784
certain gene mutations0.593801
Screening trials0.573937
Cancer Care page0.570337
breast cancer0.60178
people0.685308
absolute risk0.574938
standard screening test0.598763
survival time0.567302
screening test0.737252
cancer screening tests0.703056
cancer information summaries0.578991
screening procedures0.580721
comprehensive cancer information0.579656
long cancer patients0.576239
screening mammogram0.574868
cancer0.928642
information0.71123
risk0.62101
research studies0.609116
CLICK HERE
1885 National Cancer Institute Html es Tratamiento de los cánceres poco comunes en la niñez (PDQ®)–Versión para profesionales de salud Resumen de información revisada por expertos acerca del tratamiento de los cánceres poco comunes en la niñez como los cánceres de la cabeza y el cuello, el tórax, el abdomen, el aparato reproductor, la piel y otros.
Group Childhood Cancer0.303634
Kadish Estadio Descripción0.300271
cancer statistics0.326488
pediatric rare tumors0.992234
patients with relapsed0.372754
cuadro clínico0.354432
Advanced Solid Tumors0.370423
estadificación posoperatoria0.711901
GPOH Pediatric Rare0.343984
cooperative study group0.363939
Sin embargo0.560837
ATA Task Force0.473736
Pediatric Patients with0.461297
Childhood Cancer Research0.442875
cuáles pacientes0.308117
Targeted Therapy Directed0.368386
Treating Pediatric Patients0.460472
or histiocytic disorders0.361605
Internet ClinicalTrials.gov0.45578
metástasis distantes0.307395
Children's Oncology Group0.570172
niños vs0.418573
International Classification0.392171
or refractory advanced0.367754
tiroides medular nem20.365237
very rare tumors0.299588
Refractory Advanced Solid0.36854
carcinoma nasofaríngeo0.834137
Pediatric Molecular Analysis0.447293
Pediatric MATCH0.923242
pediatric thyroid cancer0.456559
End Results0.382399
gammagrafía ósea0.326636
BRAF V600E0.354329
Childhood Cancer0.803535
relapsed or refractory0.373353
efectos tardíos0.368787
ATA Pediatric Risk0.307191
menudo metástasis0.316315
Riesgo pediátrico intermedio0.363674
rare pediatric tumors0.355894
PDQ Tratamiento0.348659
mutaciones braf v600e0.349145
NCI-COG Pediatric Molecular0.449773
gammagrafía diagnóstica0.608069
Clin Oncol0.421865
subgrupo xi0.374046
with relapsed or0.368469
european cooperative study0.370036
CLICK HERE
1984 National Cancer Institute Html es Cuidados médicos de apoyo en niños (PDQ®)–Versión para profesionales de salud Resumen de información revisada por expertos acerca de la peculiaridad de los asuntos que surgen durante y después del tratamiento en los niños con cáncer y como sobrevivientes adultos de cáncer.
among adult survivors0.308012
Dev Behav Pediatr0.311435
Last BF0.307728
randomized controlled trials0.307154
childhood cancer survivors0.686811
Arch Gen Psychiatry0.307642
largo plazo0.386463
American Cancer Society0.324849
Child Adolesc Psychiatry0.308067
posttraumatic stress symptoms0.324331
health-related quality0.319663
Child Health Care0.307161
adult survivors0.332882
Hobbie WL0.307769
suicidal ideation0.309111
Pediatr Psychol0.406392
stress symptoms during0.307126
Health Care0.307239
Grootenhuis MA0.307795
Pediatr Nurs0.308601
childhood cancer0.948281
cancer survivor study0.418789
células madre0.316714
young adult survivors0.314912
Phipps S0.31239
adultos jóvenes0.324674
Cancer Suppl0.320779
Children’s Oncology Group0.311705
leucemia linfoblástica aguda0.307137
Cancer Facts0.31467
posttraumatic stress0.424392
Pediatr Blood Cancer0.341708
sobrevivientes adultos0.315742
efectos tardíos0.308299
report from0.327686
childhood leukemia0.320175
during treatment0.3081
Pediatr Oncol Nurs0.312201
children with0.442277
bone marrow transplant0.30728
Pediatr Oncol0.312328
Pediatr Hematol Oncol0.312789
Clin Oncol0.319255
sistema nervioso central0.312739
tensión traumática0.309229
Zebrack BJ0.312471
surviving childhood0.31989
Gartstein MA0.308683
Zeltzer LK0.312906
CLICK HERE
2055 National Cancer Institute Html es Obesidad y cáncer Hoja informativa que resume la evidencia que relaciona el sobrepeso y la obesidad al riesgo de cáncer.
body mass0.350143
Cancer Research Fund0.305964
Wang F0.302675
IMC Categoría0.303709
ligero aumento0.313291
anthropometric factors0.304184
pooled analysis from0.302634
Wang X0.302352
observational studies0.307777
male breast0.30286
risk factors0.317009
Kitahara CM0.305306
to modifiable factors0.302578
ovarian cancer0.313319
Estados Unidos0.306361
mechanisms linking obesity0.302489
PubMed Abstract0.981157
Women's Health Initiative0.305794
obesity prevalence among0.302851
endometrial cancer0.302426
Clinical Oncology0.31976
obesidad causa0.307215
prospective observational studies0.307481
International Journal0.314669
gallbladder cancer0.310353
body size throughout0.303222
United States0.304211
Renehan AG0.302352
Body Fatness0.302339
mayores riesgos0.303903
hormonal risk factors0.304977
dose-response meta-analysis0.303474
Cancer Research0.314608
PLoS Medicine0.303294
epidemiological studies0.304197
Cancer Prevention Trial0.306279
Current Oncology Reports0.302446
different risk factors0.304931
systematic review0.305695
Annual Review0.302768
risk according0.303418
Excess body weight0.303071
physical activity0.302433
pooled analysis0.316054
Cancer Institute0.315531
lymphedema risk factors0.304822
JAMA Oncology0.304192
prospective studies0.331726
New England Journal0.306423
CLICK HERE
3563 National Cancer Institute Html en Jonathan S. Wiest, Ph.D. Dr. Jonathan S. Wiest obtained a bachelor’s degree in analytical chemistry from the University of Wisconsin-Milwaukee in 1980.
North Carolina0.409045
Wisconsin-Milwaukee0.254953
Merit0.234346
Cincinnati0.232275
Associate Director0.407274
lung cancer0.424227
tumor suppressor genes0.574882
Department0.23225
major training activities0.564519
Ph.D.0.233553
Jonathan S. Wiest0.863013
Distinguished Service Award0.551249
graduate school0.424709
rank0.235426
Dr. Wiest0.997677
Senior Staff Fellow0.581562
Environmental Health0.594668
National Postdoctoral Association0.552911
P-L Biochemicals0.44241
Cancer Training0.545462
degree0.236458
pathways0.234519
oligonucleotides0.254305
major focus0.390603
University0.266416
Research Triangle Park0.595619
lung tumorigenesis0.406774
Environmental Health Sciences0.585151
analytical chemistry0.428974
Cancer Research Institute0.616451
annual meeting0.38327
National Cancer Institute0.597756
NCI Outstanding Mentor0.614163
production chemist0.439071
assistant professor0.400629
National Institute0.418588
western Colorado0.405661
Center0.289661
bachelor0.23726
NCI Director0.467597
genetic alterations0.402361
Medical College0.424659
extramural communities0.42187
NIH Director0.428955
CCT0.328048
Ohio0.235704
Toledo0.23553
NIH Award0.427672
CLICK HERE
16381 National Cancer Institute Html es Características genómicas de los cánceres infantiles (PDQ®)–Versión para profesionales de salud Resumen de información revisada por expertos acerca de las características genómicas de los cánceres infantiles. En este sumario se describen los subtipos moleculares de tipos específicos de cáncer infantil y las características clínicas relacionadas, las alteraciones genómicas recurrentes que caracterizan cada subtipo en el momento del diagnóstico o recidiva, y la importancia terapéutica y pronóstica de estas alteraciones. Se tratan las alteraciones genómicas relacionadas con tumores de encéfalo, tumores de riñón, leucemias, linfomas y otros tipos de cáncer.
frecuencia mutaciones0.528888
genes mll0.472072
Pediatric Acute Myeloid0.497416
fusión npm-alk0.439451
gen runx1t10.441044
North America0.442782
IKZF1Las deleciones0.453665
Sin embargo0.617309
Katherine Tarlock0.44723
mutaciones h3.30.551025
necesarias mutaciones0.521725
secuencias codificadoras gfi10.437106
LLA hiperdiploide0.80788
fusión il3-igh0.467917
subtipo fab0.455149
Ampliar Figura0.451303
Pediatric Clinics0.456212
Soheil Meshinchi0.449095
gen etv60.449542
principales genes0.447125
Otro gen0.448963
GFI1 family oncogenes0.435878
alteraciones genómicas tipo0.497294
Genomic Variants0.448917
gen mll0.771285
células madre0.513259
recaídas tardías0.468538
leucemia linfoblástica aguda0.548223
fusión bcr-abl10.481925
tipo ii0.523537
gen runx10.541242
fusión etv6-runx10.484276
cromosoma filadelfia0.948411
Acute Myeloid Leukemia0.490135
valor pronóstico adverso0.452162
Acute Lymphoblastic Leukemia0.435296
células leucémicas hiperdiploides0.488327
gen cbf-beta0.443623
Age Group0.442656
cromosomas hiperdiploidía0.455258
Predisposition Genes0.44826
fusión tcf3-hlf0.515862
mutaciones activadoras0.657624
Pediatric Oncology Group0.437603
Therapeutic Implications0.450243
genes jak0.448326
Oncology Group0.451583
subtipo fab m20.437855
determinados cánceres0.434561
CLICK HERE
16696 National Cancer Institute Html en Understanding Cervical Changes: A Health Guide for Women Explains abnormal Pap test, HPV test, and Pap/HPV cotest results. Treatment and follow-up care for abnormal cervical cancer screening results including ASC-US, AGC, LSIL, ASC-H, HSIL, AIS. Learn about colposcopy, types of biopsies, CIN, and HPV vaccine.
cervical screening test0.296143
cervical cancer cells0.337703
health care provider0.931179
cause cervical cancer0.303315
abnormal cervical changes0.298611
HPV types0.331542
hpv infections0.33479
abnormal cervical cell0.295805
different HPV test0.298266
cervical screening tests0.300727
cervical cells0.440061
HPV test work0.298659
test results0.460749
abnormal cervical screening0.340129
HPV test0.548179
cervical cancer screening0.419584
HPV test result0.334901
pap test0.669223
cervical cancer0.659605
abnormal test result0.292044
high-risk hpv types0.317446
HPV test results0.312992
high-risk HPV infection0.300301
women0.2963
treatment0.297209
abnormal cervical cells0.352195
HPV vaccination0.281435
Follow-Up Testing section0.335149
HPV vaccine0.303379
routine HPV testing0.291048
HPV0.555747
Pap test result0.316098
Low-risk HPV types0.299422
cervical cell changes0.36625
Cervical screening recommendations0.28727
abnormal pap test0.394575
abnormal cervical cancer0.33209
HPV vaccine series0.282155
Normal Pap test0.282878
Unsatisfactory Pap test0.281328
Possible next steps0.307487
common abnormal Pap0.287706
HPV tests0.293108
pap test results0.389844
HPV infection0.355986
abnormal cervical tissue0.293862
recent abnormal Pap0.289466
Cervical Cancer Treatment0.291973
CLICK HERE
16835 National Cancer Institute Html en Northwestern University — Cancer Nanotechnology Training Program The focus of the Northwestern University Cancer Nanotechnology Training Center is presented here.
biological properties0.685837
NU CCNE0.813714
trainees0.492664
Objectives0.460665
cancer nanomaterials0.715227
Ph.D0.461621
tools0.451616
basic courses0.711616
research-based experiences0.739642
skills0.492332
career development programs0.972187
MD0.452108
PhD-level investigators0.739449
centers0.44872
National Cancer Institute0.928332
Principal Investigator0.787408
translational research0.758394
clinical oncology0.731649
International Institute0.698015
needs0.449442
Faculty0.448884
Northwestern CNTC website0.922154
Gayle Woloschak0.790491
cancer patients0.717775
eventual goal0.748956
BioNanotechnology0.51845
well-rounded curriculum0.761183
efficacy0.474176
nanotechnology resources0.803175
principles0.451682
Training Focus0.735308
cancer biology0.721666
training program0.906256
CLICK HERE
17287 National Cancer Institute Html es Búsqueda de servicios médicos Sugerencias para elegir a un doctor o un establecimiento de tratamiento, opciones de cuidados médicos, atención a domicilio y cuidados para pacientes terminales.
teléfono al ACoS0.406963
practicantes miembros0.405783
línea quality check0.40869
es el doctor0.42878
Asociación Estadounidense0.423296
usa rayos0.406918
cirujanos miembros0.406162
cuenta los costos0.406987
capacitación de residencia0.407585
Atención Médica Asequible0.412098
Especialistas Médicos0.407972
la asociación médica estadounidense0.414538
información sobre cobertura0.405498
International Cancer Control0.40739
Colegio Estadounidense0.438106
seguro médico0.61246
Seguros Médicos0.413052
Oncología Clínica0.406552
pagar el tratamiento0.41398
paciente satisface los requisitos0.408803
Comisión Conjunta0.429316
Oncólogo radiólogo0.407999
los estados unidos0.40683
atención médica0.448896
Estados Unidos0.919617
información a disposición0.40585
cuestiones de viaje0.405374
CLICK HERE

 

 

 

Terms of Use | Privacy Policy
©2017 ARCHES Technology. All Rights Reserved.